Tilray Brands, Inc. (TLRY)


+0.03 (+0.96%)
Symbol TLRY
Price $3.15
Beta 2.620
Volume Avg. 25.43M
Market Cap 1.514B
Shares () -
52 Week Range 3.02-17.48
1y Target Est -
DCF Unlevered TLRY DCF ->
DCF Levered TLRY LDCF ->
ROE 0.36% Neutral
ROA 0.27% Neutral
Operating Margin -
Debt / Equity 25.03% Neutral
P/E 8.75 Strong Buy
P/B 0.33 Neutral


Consensus EPS

Upgrades & Downgrades

Latest TLRY news

Mr. Brendan Kennedy
Drug Manufacturers—Specialty & Generic
NASDAQ Global Select

Tilray Brands Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. It operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. The company provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. It offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. The company operates Tilray Medical, a medical platform that provides GMP-certified flowers, oils, vapes, edibles, and topicals. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Tilray, Inc. Tilray Brands Inc. was incorporated in 2018 and is headquartered in New York, New York.